UAB is leading a team of researchers in a trial to combat blood pressure risk factors.
An interdisciplinary effort among the College of Arts and Sciences and several schools across campus results in a $2.5 million grant.
A series of fascinating studies at Harvard University showed that many people respond positively to placebo pills — even when they are told that the pills don't have any active ingredients. Now researchers at UAB have partnered with a Harvard scientist to test these "open-label" placebos for the first time in cancer survivors.
This improvement in cognition persists despite a high-glycemic-index diet, a possible risk factor for Alzheimer’s.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.
A one-year, 20 percent increase in research grants elevates UAB to No. 10 among public universities receiving National Institutes of Health funding.
Sixteen clinical centers and 30 hospitals will enroll up to 5,700 pregnant women to evaluate the benefits and harms of pharmacologic treatment of mild chronic hypertension in pregnancy.
New research shows while there’s an association between breakfast habits and obesity, some practices by scientists have led the evidence for a causal claim to be exaggerated.
Studies in recent years had suggested that cilia regulate vital processes including growth, appetite, mood, healing and vision.
The finding may help to avert more of the bleeds and blood clots that come when a patient’s starting dose misses the drug’s narrow safety window.